Kubo, Kohmei
Hori, Mitsuo
Ohta, Kensuke
Handa, Hiroshi
Hatake, Kiyohiko
Matsumoto, Morio
Hagiwara, Shotaro
Ohashi, Kazuteru
Nakaseko, Chiaki
Suzuki, Kenshi
Ito, Shigeki
Kinoshita, Gen
Shelat, Suresh G.
Miyoshi, Masafumi
Takezako, Naoki
Funding for this research was provided by:
Bristol-Myers Squibb K.K.
Article History
Received: 22 August 2019
Revised: 27 September 2019
Accepted: 30 September 2019
First Online: 7 November 2019
Compliance with ethical standards
:
: MH reports post-marketing surveillance study fees from Celgene, Fujifilm RI Pharma, and Shire Japan. K Ohta reports honoraria from Bristol-Myers Squibb K.K., Celgene K.K., Janssen Pharmaceutical K.K., Novartis Pharma K.K., Ono Pharmaceutical Co. Ltd, and Takeda Pharmaceutical Co. Ltd. HH reports research grants from Celgene, Takeda Pharmaceutical, Astellas Pharma, Daiichi Sankyo, Sanofi, MSD, Kyowa Hakko Kirin, Chugai Pharmaceutical, Pfizer, Otsuka Pharmaceutical, and Ono Pharmaceutical, and honoraria from Celgene, Takeda Pharmaceutical, Daiichi Sankyo and Ono Pharmaceutical. KH reports honoraria from Bristol-Myers Squibb K.K., Ono Pharmaceutical Co. Ltd, Takeda Pharmaceutical Co. Ltd., Taiho Pharmaceutical, Johnson & Johnson, Celgene, AbbVie, Eisai, MSD, Kyowa Hakko Kirin, Novartis and Chugai Pharmaceutical, and consultancy from Otsuka Pharmaceutical and Meiji Seika Pharma. M Matsumoto reports honoraria from Janssen Pharmaceutical, Celgene, Takeda Pharmaceutical, Ono Pharmaceutical, Bristol-Myers Squibb K.K., Daiichi Sankyo, and Kyowa Hakko Kirin. SH reports a grant for investigator sponsored research from Bristol-Myers Squibb K.K. CN reports honoraria from Bristol-Myers Squibb K.K., Celgene K.K., Janssen Pharmaceutical K.K., Novartis Pharma K.K., and Takeda Pharmaceutical Co. Ltd, and research funding from Bristol-Myers Squibb K.K., Ono Pharmaceutical Co. Ltd, and Takeda Pharmaceutical Co. Ltd. KS reports personal fees from Celgene, Janssen Pharmaceutical, Takeda, Novartis, Bristol-Myers Squibb K.K., and Sanofi. SI reports honoraria from Bristol-Myers Squibb K.K., Celgene K.K., Janssen Pharmaceutical K.K., Ono Pharmaceutical Co. Ltd, and Takeda Pharmaceutical Co. Ltd. GK and M Miyoshi report employment by Bristol-Myers Squibb K.K. SGS reports employment by and equity ownership in Bristol-Myers Squibb. K.K., K Ohashi, and NT declare no competing financial interests.
: The Bristol-Myers Squibb policy on data sharing may be found at ExternalRef removed.